Thank you for your question, Mr. Blanchette‑Joncas.
It's obviously nonsensical to think that private insurance plans could act as supplementary insurers. There's no viability there. I'm not an insurance expert, but based on what's done in Quebec, it wouldn't work. These are comprehensive plans that provide comprehensive drug coverage in most cases. This also gives SMEs access to private insurance plans, to group plans. SMEs aren't required to join those plans; they could decide not to join one and then get public insurance. However, for marketing reasons or reasons of their own, they can opt for a group plan. I think that's a good thing; it's a good arrangement to offer their employees. I think that should continue as is.
In addition, these plans frequently offer broader coverage than the public plan. The public plan in Quebec already offers broad coverage. If you compare Quebec's scope to what's offered in the national plan for diabetes, you can also see a major difference in molecule access.